Standard Lithium welcomes Dr. Volker Berl to its Board as Independent Director

– CANADA, Vancouver –  Standard Lithium Ltd. (TSX: SLI | NYSE American: SLI | FRA: S5L), an innovative technology and lithium project development company, today announced the appointment of Dr. Volker Berl to its Board as an independent director effective immediately.

“I am pleased to welcome Dr. Berl to the board at this significant juncture in the Company’s evolution,” said Board Chair, Robert Cross. “Dr. Berl’s deep knowledge of the chemical industry coupled with his experience in institutional capital markets and an outstanding track record of investments in technology companies will be extremely valuable as we advance our goal of bringing the first new US lithium project into production in over 50 years.”

About Dr. Volker Berl

Dr. Berl has been a venture builder and an avid serial investor since 2009. He is the Founder, Managing Partner, and CEO of New Age Ventures, a venture studio with a portfolio of earlier stage and actively managed investments across healthcare, medical devices, digital health, cleantech, consumer tech, deep tech, applied artificial intelligence, and more. Mr. Berl is well connected in the New York technology investment community and currently serves as a director for Gaussin S.A. (EPA: ALGAU), Leaderlease S.A., OrthogenRx, Inc., Venock, Inc., Emoshape, Inc., and Artract Medical, Inc.

Dr. Berl has held positions with BASF AG in Germany, from 2002 to 2005 in chemical manufacturing and process engineering, and in global new business development for chemical intermediates. In 2006, he was VP Equity Research Pharmaceuticals for Deutsche Bank and CTO for bioscience company Zymes LLC from 2007 to 2009.

Dr. Berl holds an M.B.A. in General Management from Concordia University (Canada), a post-doctoral chemistry fellowship from Stanford University (USA), a Ph.D. in Chemistry from the University of Strasbourg (France), a Masters in Chemical Engineering from the École Nationale Supérieure de Chimie, Polymères et Matériaux (France), and an M.Sc. in Chemistry from the Eidgenössische Technische Hochschule (Switzerland).

“I am excited to expand my involvement with Standard Lithium on the heels of the recent NYSE American listing and technological achievements,” said Dr. Berl. “I look forward to representing shareholders and working closely with the board and team as they continue to execute on their strategic developments plans”.

About Standard Lithium Ltd.

Standard Lithium is an innovative technology and lithium development company. The company’s flagship project is located in southern Arkansas, where it is engaged in the testing and proving of the commercial viability of lithium extraction from over 150,000 acres of permitted brine operations. The company has commissioned its first-of-a-kind industrial-scale direct lithium extraction demonstration plant at Lanxess’s south plant facility in southern Arkansas. The demonstration plant utilizes the company’s proprietary LiSTR technology to selectively extract lithium from Lanxess’s tail brine. The demonstration plant is being used for proof-of-concept and commercial feasibility studies. The scalable, environmentally friendly process eliminates the use of evaporation ponds, reduces processing time from months to hours, and greatly increases the effective recovery of lithium. The company is also pursuing the resource development of over 30,000 acres of separate brine leases located in southwestern Arkansas and approximately 45,000 acres of mineral leases located in the Mojave Desert in San Bernardino County, California.

For more information: https://www.standardlithium.com/

- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.

Talent4Boards Team